Takeda Pharmaceutical is an outcome of selling traditional Japanese and Chinese herbal medicines in 1781. In Doshomachi, the Chobei Takeda I begin selling in the district of Osaka, Japan. The founder gained a reputation for business integrity and quality products and services. These values continue through the years and become implanted into its corporate philosophy, which still guide the company today.
The company is a consumer-focused, values-based, R&D-driven global biopharmaceutical company that is committed to bring better health. The company is present in approximately 80 countries in leading positions, includes Japan and the U.S. In the U.S. it has first largest pharmaceutical market in the world. Takeda Pharmaceutical delivers highly innovative medicines and care for huge populace across the globe.
Logo of Takeda Pharmaceutical mark for overseas is an updated and modern version with ‘Embracing Mountains’ (Dakiyama) mark. The leading company merged with Zydus pharmaceuticals to form a new 100% export-oriented unit.
Combinedly the both companies have two manufacturing plants, API Plant and KSM Plant. The global team of researchers and scientists are partners to harness the cutting-edge science that push the boundaries of transformation with life-changing therapies.